AFT to distribute NovaTears in AUS and NZ
AFT Pharmaceuticals (AFT) has completed a licensing agreent with German specialty pharmaceutical company Novaliq that allows it to distribute NovaTears ...
AFT Pharmaceuticals (AFT) has completed a licensing agreent with German specialty pharmaceutical company Novaliq that allows it to distribute NovaTears ...
Zeiss has announced the release of a new glaucoma application in Australia, which integrates structure and function into one report.
Transitions is trying to encourage a younger generation of single vision wearers to the photochromic market.
The Federal Government has confirmed it will continue to fund the Visiting Optometrists Sche (VOS) for at least the next ...
A team of Melbourne scientists has taken the first steps towards to curing a rare eye disease that leads to ...
Despite blindness ranking as the most feared ailment in a survey of US citizens, most respondents were still unaware of ...
Registration statistics released by the Optometry Board of Australia (OBA) show more than half of Australia’s optometrists are now endorsed ...
Clinical tests are underway for a type of auto-regulating lens that could make contact lenses and eyeglasses a thing of ...
The ophthalmic healthcare sector has expressed concern at the proposed expansion of comments on medical review websites to include information ...
The Fred Hollows Foundation has issued a call for governments worldwide to do more to combat avoidable blindness, after new ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited